Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2026-03-08 @ 1:58 AM
Study NCT ID:
NCT03804866
Status:
COMPLETED
Last Update Posted:
2019-01-15
First Post:
2018-10-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Sponsor:
AGC Biologics S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NGR018-IPR/26
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None